Dr. David Tate, who earned his PhD in psychology with an emphasis in neuropsychology from Brigham Young University and is pictured above, is joining UMSL’s Missouri Institute of Mental Health (MIMH) as Associate Research Professor effective April 1, 2015.
Tate brings to the MIMH an active research program with a history of substantial NIH and DoD support that explores the biological and cognitive benefits of cognitive rehabilitation treatments for service members with a traumatic brain injury.
According to Dr. Rob Paul, Professor of psychology and Director of MIMH, Tate will “continue and build his research program aimed at defining the neurological mechanisms of traumatic brain injury with a particular focus on blast-related injuries in veterans and sports-related traumatic brain injuries. His program utilizes state-of-the-art neuroimaging methods and sensitive clinical tools to understand the mechanisms of these injuries and potential avenues for effective intervention and treatment.”
Tate said he hopes to support the MIMH mission by conducting innovative research that “benefits patients suffering traumatic brain injury and leads to new treatment strategies.”
He completed a clinical internship in neuropsychology and a post-doctoral fellowship in immunology at Brown University after which he joined the research faculty at Brown for a year. He has also held academic positions at Brigham and Women’s Hospital, Harvard Medical School and Boston University Medical School. Most recently, Tate worked as a research neuropsychologist and senior principle scientist for the Defense and Veterans Brain Injury Centers at the Brooke Army Medical Center in San Antonio. There he worked with active duty service members who sustained head injuries during combat operations or training exercises in both clinical and research capacities. In addition, he has also begun working with researchers examining the imaging and cognitive effects that high altitude flying has on pilots working in decompressed environments. Over the course of his career, he has studied the cognitive and medical imaging effects of a number of neurologic diseases, dementia, development disorders, and acquired brain disorders.